M. Sankey

发表

Preliminary observations on the excretion of acebutolol and its acetyl metabolite in the urine and faeces of man

R. Gabriel, C. Kaye, M. Sankey, 1981, The Journal of pharmacy and pharmacology.

Acebutolol and coronary artery surgery

C. Kaye, M. Sankey, G. Thoms, 1982, Anaesthesia.

A rapid and specific semi-micro method involving high-pressure liquid chromatography for the assay of metronidazole in plasma, saliva, serum, urine and whole blood.

C. Kaye, M. Sankey, L. Thomas, 1980, British journal of clinical pharmacology.

The penetration of metronidazole into synovial fluid.

C. Kaye, M. Sankey, M. Cawley, 1982, Postgraduate medical journal.

A simple and sensitive H.P.L.C. method for the assay of prochlorperazine in plasma.

C. Kaye, M. Sankey, J. Holt, 1982, British journal of clinical pharmacology.

The penetration of trimethoprim and sulphamethoxazole into synovial fluid.

C. Kaye, M. Sankey, M. Cawley, 1983, The Journal of antimicrobial chemotherapy.

A high-pressure liquid chromatographic methods for the assay of ketoprofen in plasma and urine, and its application to determining the urinary excretion of free and conjugated ketoprofen following oral administrations of Orudis to man.

C. Kaye, M. Sankey, J. Holt, 1981, British journal of clinical pharmacology.

Changes in plasma concentrations of acebutolol, propranolol and indomethacin during physical exercise.

C. Kaye, M. Sankey, P. Turner, 1981, Life sciences.

Serum, saliva, and sputum levels of metronidazole in acute exacerbations of chronic bronchitis.

C. Kaye, M. Sankey, A. T. Willis, 1981, Thorax.

Concentration of metronidazole and its major metabolites in continuous ambulatory peritoneal dialysate.

R. Gabriel, C. Kaye, M. Sankey, 1983, The Journal of antimicrobial chemotherapy.

Preliminary study of the disposition in man of acebutolol and its metabolite, diacetolol, using a new stereoselective hplc method

C. Kaye, M. Sankey, A. Gulaid, 1984, The Journal of pharmacy and pharmacology.

The pharmacokinetics of acebutolol in man, following the oral administration of acebutolol HCl as a single dose (400 mg), and during and after repeated oral dosing (400 mg, b.d.).

C. Kaye, M. Sankey, R. Templeton, 1981, Biopharmaceutics & drug disposition.

Lack of correlation between acetylator status and the production of the acetyl metabolite of acebutolol in man.

C. Kaye, M. Sankey, R. Templeton, 1978, British journal of clinical pharmacology.

THE ELIMINATION OF PRACTOLOL BY TWO HUMAN SUBJECTS

C. Kaye, M. Sankey, .. Roberts, 2006 .